knowledge -WSS

knowledge

author：Wikipedia 2025-09-29 13:09:59 - browse：51

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, at a hearing — policy coverage from STAT — Peter Marks, director of the FDA's Center for Biologics Evaluation and Research Greg Nash/Pool via AP

WASHINGTON — A top Food and Drug Administration official wants Congress to dedicate full-time staff to emerging pathogens, after the FDA scrambled to find people for Covid-19 priorities like Operation Warp Speed.

“Vaccines were a pretty heavy duty lift during the pandemic,” said Peter Marks, director of the Center for Biologics Evaluation and Research, at a Thursday Politico event. “Rather than having to essentially reassign whole groups of people and disrupt things, the idea is to have a group of people who are constantly working on this.”

There is reason for optimism. Sens. John Hickenlooper (D-Colo.) and Ted Budd (R-N.C.) successfully added an amendment creating that team to a key pandemic preparedness bill that must be reauthorized by the end of September. It would establish this new program within Marks’ division of the FDA, staffed with experts on vaccines, antibodies, diagnostic tests, personal protective equipment, and other medical countermeasures. Among other activities, this team would enhance surveillance programs and prioritize vaccine research and development so that existing platforms can be retooled to fight other viruses.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： BIO selects John Crowley as new CEO

entertainment

WSS

Rep. Raul Ruiz on the physician shortage and more

UnitedHealth’s Optum accused of antitrust violations in California

Takeda, Janssen join wearable maker to measure scratching

Newly revealed memo details efforts to keep Trump in power following election loss

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

Will the market for weight loss drugs really reach $100 billion?

focus

knowledge

hotspot

New air purifier tech could be key to improving indoor air quality

Flagship Pioneering launches a new biotech in two countries

The high cost of giving birth even with insurance

TB outbreak tied to bone grafts underscores testing shortcomings

Supreme Court strikes down use of affirmative action

CDC director unscathed in first congressional testimony

Drug repurposing or repositioning? The language matters

Large hospital system sues Multiplan for low

Medical leaders decry Supreme Court decision on affirmative action

TB outbreak tied to bone grafts underscores testing shortcomings

focus

Rep. Raul Ruiz on the physician shortage and more

Diagnostic tests are hitting their mathematical limits

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

The history of OxyContin, told through Purdue Pharma documents

Maui funeral service workers on devastation of fires: 'I'm in shock'

White House drug shortages task force keeps mum with Congress

hotspot

entertainment

knowledge

entertainment